
Eric C. Blackstone/researchgate.net
Jan 24, 2025, 03:13
Timely Reporting of Patient-Reported Outcomes in Cancer Clinical Trials
Amy C. Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared an article by Eric C. Blackstone, on LinkedIn:
“With the increasing utilization of surrogate endpoints (eg PFS) in cancer clinical trials, the timely collection AND reporting of patient- reported outcomes (PROs) is essential.
This article offers a great overview of the issue.”
Timely Reporting of Patient-Reported Outcomes in Cancer Clinical Trials: An Ethical Imperative.
Authors: Eric C. Blackstone, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20
Feb 20, 2025, 11:19
Feb 20, 2025, 11:13
Feb 20, 2025, 11:08
Feb 20, 2025, 11:00